While colorectal and hepatic resections are commonly performed through a laparoscopic approach, the safety and feasibility of total laparoscopic synchronous resections (LSR) of colorectal liver metastasis (CRLM) have not been established. In this systematic review, short-and long-term outcomes were comparable for patients undergoing LSR and open synchronous resection. LSR was safe and feasible for patients with synchronous CRLM and should be considered in well-selected patients. Among patients with resectable disease, surgical resection remains the only potentially curative treatment for synchronous CRLM. 4 However, the optimal operative sequence for the management of the primary tumor and metastatic liver disease remains unclear. 6 The traditional surgical strategy consists of a staged approach, in which resection of the primary tumor -with or without adjuvant chemotherapy -is followed by a planned liver resection at a future date (colorectal-first approach). Alternatively, the "reverse approach" consists of resection of liver metastases before removal of the primary tumor (liver-first approach). With improvements in surgical technique and perioperative care over the past two decades, an increasing number of patients are being managed through a combined approach comprised of synchronous resection of the primary colorectal tumor and liver metastases. 
Laparoscopic colorectal surgery and laparoscopic liver surgery are both accepted as an appropriate approach for selected patients with colorectal and liver malignancies. Indeed, minimally invasive colorectal resections are routinely performed at most centers, as their safety and efficacy are supported by large randomized controlled trials. [13] [14] [15] Laparoscopic liver resections (LLR) for primary and metastatic liver lesions are also increasingly being performed. LLR is now recognized to be safe, with several series reporting that margins after LLR of CRLM, as well as oncological outcomes, are equivalent compared with open resection. [16] [17] [18] Moreover, the laparoscopic approach may offer several benefits such as faster recovery, less postoperative pain, shorter hospital length-of-stay (LOS), and lower postoperative morbidity. 18 Nevertheless, whether SR can be performed safely and efficiently in a pure minimally invasive fashion remains unclear.
The purpose of this systematic review was to evaluate the safety and feasibility of laparoscopic synchronous resection (LSR) of the primary colorectal cancer (CRC) and the CRLM.
| MATERIALS AND METHODS

| Study design
The present study was designed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 19 Three authors independently searched the literature (NH, NM, and AP). No language restrictions were applied. All appropriate prospective and retrospective studies addressing outcomes of patients with CRLM who underwent synchronous pure laparoscopic resection of the primary CRC and CRLM were considered eligible for inclusion.
Studies that reported at least one postoperative outcome (operative time, estimated blood loss [EBL] , LOS, morbidity, and recurrence or survival rates) were included. Exclusion criteria included: (1) studies analyzing outcomes after hand-assisted or hybrid techniques, (2) review articles, (3) case reports, and (4) 
| Literature search and data collection
Identification of eligible studies was performed through a systematic search of the literature using Medline, Scopus, Google Scholar, and clinicaltrials.gov databases until June 2018. The reference list of the selected studies was manually assessed for the detection of potentially relevant articles. The following keywords were used for the search: "laparoscopy," "laparoscopic," "minimally invasive," "liver metastasis," "colorectal cancer," "stage 4," "combined resection,"
"simultaneous resection," and "synchronous resection."
3 | RESULTS
| Article selection
A total of 12 studies that included patients who underwent LSR of the primary colorectal tumor and CRLM were considered eligible [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] ; while four studies were noncomparative (n = 63 patients), [20] [21] [22] [23] the remaining eight studies were comparative and analyzed postoperative outcomes of 136 patients who underwent LSR versus 171 patients who underwent OSR. [24] [25] [26] [27] [28] [29] [30] [31] The indices analyzed were tabulated in three structured tables as follows: patient characteristics (Table 1) , operative details (Table 2) , and long-term outcomes (Table 3) . A total of eight studies were excluded [32] [33] [34] [35] [36] [37] [38] [39] due to the inclusion of hand-assisted approach (n = 5), 37 combination of open liver resection with laparoscopic colectomy, 38 inclusion of robot-assisted liver resections, 36 and the inclusion of non-CRLM liver lesions. Table 3 (Table 2) . 27, 29 The LSR group had three complications graded as Clavien-Dindo ≤ II and four complications graded as Clavien-Dindo ≥ III. In contrast, among patient who underwent OSR ten and five complications were Clavien-Dindo grade ≤ II and Clavien-Dindo grade ≥ III, respectively. 22, 23 Thirty-day mortality among patients who underwent LSR was 1% (n = 2) versus 0.5% (n = 1) for patients who underwent OSR.
Only seven studies compared long-term outcomes among patients undergoing LSR and OSR (Table 4 ). There were no differences in 1-, 3-, or 5-year overall survival [24] [25] [26] 29, 31 or disease-free survival 28-31 among patients undergoing SLR versus OLR (all P > 0.05).
| DISCUSSION
Advances in surgical technique, innovations in operative instrumentation, and improvements in anesthesia have facilitated the ability to perform synchronous laparoscopic colorectal and hepatic resection.
While widely adopted in colorectal surgery, the use of the minimally invasive approach has only more recently been broadly embraced for liver surgery. In addition, the use of the minimally invasive approach Importantly, among patients undergoing LSR, long-term oncologic outcomes, such as overall and disease-free survival, were also comparable with patients who underwent OSR.
To date, no randomized controlled trials have been performed to assess the optimal operative sequence for patients with synchronous CRC and CRLM. 40 Traditionally, the colorectal-first staged approach has been considered the standard treatment strategy for patients with resectable disease. 41 Alternatively, the liver-first approach has been advocated as an appropriate strategy to avoid progression of the liver metastases between the timing of the colorectal and hepatic surgeries. [42] [43] [44] The substantial decrease in morbidity and mortality associated with liver resection during the past two decades has led to the questioning of the classic paradigm of staged resection. In fact, SR of primary CRC and CRLM may even be favored for select patients. 6 Several potential advantages of the SR approach include the elimination for two major operations, shorter overall hospital stay, and reduced costs, as well as comparable morbidity and mortality compared with the staged approach. 6, 12, 45, 46 Moreover, long-term oncologic outcomes appear to be comparable with staged resection. 6 A recent network meta-analysis that evaluated the shortand long-term outcomes for the three surgical approaches, albeit
using largely the open surgical approach, described no significant differences in terms of postoperative morbidity, mortality, or 5-year OS. 40 The were not available, and therefore could not be included in the analyses.
In conclusion, a systematic review of the literature demonstrated that LSR was a safe and feasible approach for selected patients with synchronous CRLM. Short-term outcomes for patients undergoing LSR (eg operative time, blood loss, and the incidence of postoperative complications) and long-term outcomes were similar to patients undergoing OSR. Nevertheless, the quality of evidence was poor and additional research utilizing larger sample sizes with improved statistical matching to OSR cohorts is needed to clearly define the specific subset of patients who will benefit more from the LSR. Based on current data, LSR can be considered only for highly selected patients if performed by a multidisciplinary surgical team with expertise in minimally invasive colorectal and hepatic surgery. 
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